John T. Henderson, Director at MYRIAD GENETICS INC (MYGN), bought 300 shares at $32.73 ($10K) on 2009-05-13, disclosed to the SEC on 2009-05-14.
Open-market purchase of $10k MYGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CYTK | SELL | 2025-04-16 | $247K | — | Filing → |
| CYTK | SELL | 2024-12-12 | $179K | — | Filing → |
| CYTK | SELL | 2024-04-25 | $1.4M | — | Filing → |